Protocol for the examination of specimens from patients with malignant pleural mesothelioma: a basis for checklists. Cancer Committee, College of American Pathologists.

Authors Kelly J. Butnor, MD, FCAP* Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care/University of Vermont, Burlington, Vermont Mary Beth Beasley, MD, FCAP Department of Pathology, Mt. Sinai Medical Center, New York, New York Philip T. Cagle, MD, FCAP Department of Pathology, The Methodist Hospital, Houston, Texas Steven M. Grunberg, MD Department of Hematology/Oncology, Fletcher Allen Health Care/University of Vermont, Burlington, Vermont Alberto Marchevsky, MD, FCAP Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, California Nader T. Okby, MD, FCAP Orange Pathology Associates, Middletown, New York Victor L. Roggli, MD, FCAP Department of Pathology, Duke University Medical Center, Durham, North Carolina Saul Suster, MD, FCAP Department of Pathology, The Medical College of Wisconsin, Milwaukee, Wisconsin Henry D. Tazelaar, MD, FCAP Department of Laboratory Medicine and Pathology, Mayo Clinic Scottsdale, Scottsdale, Arizona For the Members of the Cancer Committee, College of American Pathologists